Novel therapeutic compound acridine –retrotuftsin action on biological forms of melanoma and neuroblastoma

ConclusionOur data show that the biological forms of certain tumors responded in different ways to the action of ART. As a combination of retrotuftsin and acridine, the compound can be an inducer of apoptotic cell death of melanoma, especially the amelanotic form. Although the mechanism of the interrelationships between energy metabolism and cell death is not fully understood, interference of ART with TAC enzymes could encourage the further investigation of its anticancer action.

Source: Journal of Cancer Research and Clinical Oncology - January 1, 2019 Category: Cancer & Oncology Source Type: research